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The sarcomeric cytoskeleton is a network of modular
proteins that integrate mechanical and signaling
roles. Obscurin, or its homolog obscurin-like-1,
bridges the giant ruler titin and the myosin cross-
linker myomesin at the M-band. Yet, the mo-
lecular mechanisms underlying the physical ob-
scurin(-like-1):myomesin connection, important for
mechanical integrity of the M-band, remained
elusive. Here, using a combination of structural,
cellular, and single-molecule force spectroscopy
techniques, we decode the architectural and func-
tional determinants defining the obscurin(-like-1):
myomesin complex. The crystal structure reveals
a trans-complementation mechanism whereby an
incomplete immunoglobulin-like domain assimi-
lates an isoform-specific myomesin interdomain
sequence. Crucially, this unconventional architec-
ture provides mechanical stability up to forces of
135 pN. A cellular competition assay in neonatal
rat cardiomyocytes validates the complex and pro-
vides the rationale for the isoform specificity of
the interaction. Altogether, our results reveal a
novel binding strategy in sarcomere assembly, which
might have implications on muscle nanomechanics
and overall M-band organization.
INTRODUCTION
Sarcomeres, the basic contractile units of striated muscles,
specialize in force generation through cyclic interactions of
myosin and actin filaments. This fundamental activity requires
the correct positioning of hundreds of proteins assembled in
an overall functional architecture that need to respond to me-Structure 25, 1–14,
This is an open access article undchanical force in a cooperative, orchestrated way, as well as
providing key integration of regulatory signals. The Z-disc and
M-band sarcomeric regions (Figure 1A), although not directly
involved in the actomyosin complex, are hubs where multiple
structural and regulatory proteins are linked (Gautel and Dji-
novic-Carugo, 2016). In particular, the central M-band, where ti-
tin filaments entering from opposite half-sarcomeres overlap,
has been proposed as a structural safeguard of sarcomere integ-
rity during force-generation cycles (Agarkova et al., 2003).
Myomesin is a 185 kDa modular protein that localizes exclu-
sively at theM-band, where anti-parallel dimers cross linkmyosin
filaments (Figure 1B). It is expressed in all muscle types and its
knockdownbysiRNAresults in ageneral failure inM-bandassem-
bly and the formation of disordered sarcomeres (Fukuzawa et al.,
2008). Long interdomainahelices at theprotein’sC terminus have
been suggested to act as strain absorbers enabling myomesin
to buffer mechanical forces between molecules during muscle
work (Pinotsis et al., 2012; Xiao and Grater, 2014). In addition to
a mechanical role, myomesin is also needed for the integration
of obscurin and its smaller obscurin-like-1 homolog at the
M-band (Fukuzawa et al., 2008). Together with titin’s C terminus,
a hotspot for disease-related mutations (Carmignac et al.,
2007; Pollazzon et al., 2009), myomesin recruits obscurin and
obscurin-like-1 N-termini at the myofibril periphery and core,
respectively, establishing a ternary complex (Figure 1B).
Obscurin and obscurin-like-1 share a common immunoglob-
ulin (Ig)-rich modular structure, which, in the case of obscurin,
is more extended, featuring additional signaling and protein-
binding domains absent in obscurin-like-1 (Fukuzawa et al.,
2008). The presence of a non-modular C terminus able to interact
with small ankyrin-1 isoform 5 and ankyrin-2 led to the sug-
gestion that obscurin plays a role in establishing the sarco-
mere-sarcoplasmic reticulum connection (Bagnato et al., 2003;
Kontrogianni-Konstantopoulos et al., 2003). The pathophysio-
logical roles of these proteins are only beginning to emerge.
Ablation of obscurin in mice results in changes in longitudinal
sarcoplasmic reticulum architecture with alterations in several
SR-associated proteins (Lange et al., 2012) as well as markedJanuary 3, 2017 ª 2016 The Author(s). Published by Elsevier Ltd. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Schematic of the M-Band Network
(A) Principal sarcomere regions are marked by the letters Z, I, A, and M.
(B) Modular myomesin, titin, and obscurin/obscurin-like-1 proteins form an intricate M-band network with C-terminal myomesin dimers crosslinking myosin
filaments. The inset highlights the interaction between myomesin and obscurin/obscurin-like-1, which has been mapped to linker sequence (L) located between
the myomesin fibronectin (Fn-III) domains My4 and My5 and the third immunoglobulin (Ig) domain of obscurin/obscurin-like-1 (O3/OL3, respectively) (Fukuzawa
et al., 2008).
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(Randazzo et al., 2013), while its depletion in zebrafish leads to
disturbances in the extracellular matrix organization during skel-
etal muscle development (Raeker and Russell, 2011). The found-
ing member of the obscurin family of proteins is UNC-89 in Cae-
norhabditis elegans (Benian et al., 1996). unc-89 loss-of-function
mutant worms display reduced locomotion, disorganized myofi-
brils, and lack M lines (Small et al., 2004; Waterston et al., 1980).
unc-89 mutants show disorganization of myosin thick filaments
by immunostaining (Qadota et al., 2008; Wilson et al., 2012).
Drosophila expresses a protein more similar to nematode
UNC-89 than to vertebrate obscurin. In Drosophila, RNAi exper-
iments indicate that obscurin is needed for the formation of
normal symmetrical sarcomeres (Katzemich et al., 2012). How-
ever, fundamental differences exist in the domain patterns and2 Structure 25, 1–14, January 3, 2017likely functions of the signaling domains in vertebrate, insect,
and nematode obscurins/unc-89 members. All obscurin/UNC-
89 members contain a constitutively expressed Rho-type GDP/
GTP exchange factor domain (GEF) with a preceding Src-homol-
ogy-3 (SH3) domain, which in insect and nematode obscurin/
UNC-89 are situated at the N-terminal end of the proteins, while
in vertebrate obscurin, the GEF domain is at the C terminus. In
addition, obscurin/UNC-89 isoforms can contain up to two
serine/threonine kinase domains (Katzemich et al., 2012; Spoo-
ner et al., 2012). In insect and nematode obscurin, these are
catalytically inactive pseudokinases that form scaffolds for
the interactions with regulators of sarcomere assembly and/or
maintenance (Katzemich et al., 2012), while the two differentially
spliced kinases in vertebrate obscurin contain all canonical
residues required for catalysis (Fukuzawa et al., 2005) and
Table 1. X-Ray Data Collection and Refinement Statistics
Data Collection
Dataset OL3:My4L My4LH (1) My4LH (2)
Beamline I04 (DLS) I04 (DLS) I04-1 (DLS)
Wavelength (A˚) 0.9778 0.97949 0.92819
Resolution
rangea (A˚)
67.19–3.10
(3.18–3.10)
84.36–2.05
(2.11–2.05)
39.21–2.80
(2.87–2.80)
Space group C2 P65 P21
Cell dimensions
(a, b, c) (A˚) 91.18,
134.38,
68.39
97.41,
97.41,
106.15
43.53,
156.84,
48.26
(a, b, g) () 90, 92.50, 90 90, 90, 120 90, 94.38, 90
Unique reflectionsa 14,811
(1,064)
35,371
(2,587)
15,138
(1,048)
Overall redundancya 4.5 (4.5) 20.0 (20.0) 3.1 (3.1)
Completenessa (%) 99.1 (98.2) 99.9 (98.7) 95.3 (89.8)
Rmerge
a (%) 9.8 (69.8) 13.4 (242.1) 9.0 (31.4)
Rp.i.m. (I)
a (%) 6.2 (44.3) 3.6 (56.7) 8.1 (24.5)
hI/s(I)ia 12.7 (1.8) 13.4 (1.6) 10.8 (3.1)
Refinement
PDB code 5FM5 5FM8 5FM4
Rfactor (%)/Rfree (%) 21.6/25.9 19.2/21.7 26.1/28.7
Twin/twin fraction no k,h,l/0.67 no
No. of non-H
atoms
Protein 3,482 3,142 4,726
Water 84 140 37
Average B
value (A˚2)
85.5 50.1 35.2
Root-mean-square
bond lengths (A˚)
0.009 0.013 0.005
Root-mean-square
bond angles ()
1.46 1.72 1.07
aNumbers in parentheses refer to the highest resolution bin.
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gianni-Konstantopoulos, 2013). Analyzing the molecular inter-
actions and signaling functions therefore requires dedicated ap-
proaches for each of these presumptive homologs. From a
pathological viewpoint, obscurin polymorphism has been linked
to hypertrophic cardiomyopathy (Arimura et al., 2007) and
dilated cardiomyopathy (Marston et al., 2015), while mutations
in obscurin-like-1 have been linked to the rare hereditary growth
retardation 3-M syndrome (Huber et al., 2009) with a role in the
maintenance of cullin-7 levels (Hanson et al., 2009). Understand-
ing obscurin/unc-89 functions thus also bears relevance to un-
derstanding the impact of pathogenic variants in human.
To advance knowledge on M-band organization and function,
we have previously established the molecular basis for titin:obs-
curin-like-1 (Pernigo et al., 2010) and titin:obscurin (Pernigo et al.,
2015) connection at the M-band. Obscurin and obscurin-like-1
use their homologous N-terminal immunoglobulin-like (Ig) do-
mains (O1 and OL1, respectively) to bind titin’s most C-terminal
Ig domain (M10) in a mutually exclusive manner and in a uniquechevron-shaped anti-parallel Ig-Ig architecture (Pernigo et al.,
2010, 2015; Sauer et al., 2010). Mechanically, the M-band titi-
n:obscurin(-like-1) junction is labile, as in single-molecule force
spectroscopy experiments both M10:O1 and M10:OL1 com-
plexes yield at forces of around 30 pN (Pernigo et al., 2010). An
obvious missing piece in the M-band structural puzzle is the
molecular architecture of the obscurin(-like-1):myomesin com-
plex, a key elusive element to understand the global geometry
andmechanical stability defining theM-band. Using amultidisci-
plinary approach encompassing structural techniques, in vivo
cellular competition assays, and single-molecule force spectros-
copy experiments, we investigated here the myomesin-depen-
dent mechanism of obscurin(-like-1) integration at the M-band.
RESULTS
Human Obscurin/Obscurin-like-1:Myomesin Complex
for Structural Analysis
Large muscle proteins are typically modular, featuring several Ig
and fibronectin-type-III (Fn-III) domains interspersed by linkers
of variable length and structural order. Yeast two-hybrid and
biochemical analyses have mapped the obscurin/obscurin-like-
1:myomesin interaction to the linker region (L) located between
the fourth and fifth Fn-III domains of myomesin (My4 and My5,
respectively) and the third Ig domain of either obscurin or ob-
scurin-like-1 (O3 and OL3, respectively) (Figure 1B, inset) (Fuku-
zawa et al., 2008). O3 and OL3 are highly homologous, sharing
47.2% sequence identity. To produce protein complexes for
structural analysis, we initially attempted the expression of
isolated domains in Escherichia coli, but failed to obtain soluble
O3 or OL3. We therefore decided to pursue a co-expression
approach and cloned either O3 or OL3 C-terminal to a GST
tag in the first expression cassette of a bicistronic vector,
where the myomesin region encompassing the fourth and fifth
Fn-III domains (My4LMy5) was cloned in the second expression
cassette. This strategy readily produced soluble protein for both
constructs and size-exclusion chromatography (SEC) analysis
of GST-cleaved complexes is consistent with the formation of
obscurin(-like-1):myomesin heterodimers with a 1:1 stoichiom-
etry (Figure S1). Using a matrix microseeding (MMS) approach
(D’Arcy et al., 2014), we successfully crystallized the OL3:
My4LMy5complex andsolved its structure at the3.1 A˚ resolution.
X-raydata collectionand refinement statisticsaregiven inTable1.
The final model is characterized by excellent statistics andR/Rfree
(%) values of 21.6/25.9. While the myomesin My4 domain and its
C-terminal linker L aswell as obscurin-like-1 OL3 are well defined
in the structure, the entire myomesin My5 domain is invisible in
electron density maps. Proteolysis during crystallization does
not appear to be the reason for this, as SDS-PAGEanalysis of dis-
solvedcrystals showsbothMy4LMy5andOL3componentsat the
expected molecular weight (Figure S2). Thus, we conclude that
the lack of electrondensity forMy5 is due to its positional disorder
in the crystal. As My5 is not visible in the structure, we hereafter
refer to the crystallographic complex as to OL3:My4L.
Overall Organization
The OL3:My4L complex is present as a (OL3:My4L)2 dimer of
heterodimers in the crystal (Figure 2A). Individual OL3:My4L
complexes display a bent dumbbell-shaped structure, in whichStructure 25, 1–14, January 3, 2017 3
Figure 2. The (OL3:My4L)2 Complex Dimer
(A) In the crystal, two OL3:My4L heterodimers are arranged around a non-crystallographic two-fold axis (vertical in this view) forming a W-shaped (OL3:My4L)2
dimeric assembly. My4L and OL3 are in slate blue and green, respectively, with one heterodimer shown as a solid surface and the other in cartoon mode with a
transparent surface. The dotted line at the C terminus of L indicates the flexible region leading to My5 not visible in the structure.
(B) Superdex S75 10/300 SEC traces for the OL3:My4LMy5 complex injected in the column at 3 mg/mL (thin continuous line) and 8.2 mg/mL (thick continuous
line). The OL3:My4LMy5 complex forms a mixture of monomers and dimers in a concentration-dependent manner. The elution profile of calibration markers is
shown with a gray broken line. Molecular weights are indicated.
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grating within the OL3 fold. Two OL3:My4L heterodimers then
interlock around a non-crystallographic two-fold axis, giving
rise to a dimeric assembly with overall dimensions of 105 A˚ 3
48 A˚ 3 26 A˚. Large solvent channels running parallel to the
molecular dyad axis are observed in the crystallographic pack-
ing (Figure S3). These are compatible with the presence of posi-
tionally disordered My5 domains.
As the OL3:My4LMy5 complex typically elutes from SEC as a
monomeric unit during purification (Figure S1), we analyzed its
behavior at concentrations similar to that used for crystallization.
In the accessible range of 3.0–8.2 mg/mL (0.082–0.225 mM), we
observed the formation of complex dimers in a concentration-
dependent manner with an approximately 30:70 dimer:monomer
ratio at the highest protein concentration (Figure 2B). Thus, the
oligomerization state observed in the crystal reflects that of a
population in solution promoted by high protein concentration
(15.9 mM in the crystal).
The OL3:My4L Heterodimer
Three distinct structural regions that we identify as My4, LH, and
OL3A contribute to the architecture of individual OL3:My4L heter-
odimers (Figures 3Aand3B). TheMy4domaindisplays the typical
Fn-III fold made of seven anti-parallel b strands organized in
two separate b sheets (A-B-E and C-C0-F-G) arranged in a b
sandwich. C0 is rather short, while G is broken in two (G0 and G00)
and interacts with the beginning and end of the long F b strand.
C-terminal to My4, the LH spacer region encompasses the first
11 amino acids of L and is formed by a 10.6-A˚-long a helix
(Pro607-Lys614) followed by a short three amino acids peptide
(Ser615-Pro617). LH leads the C-terminal portion of L, an 18-
amino-acid-long extended stretch divided into two b strands
(LS0 and LS00) that integrate within the OL3 Ig fold. Similar to the
Fn-III architecture, the Ig fold is also organized into a b sandwich
formed by two b sheets (A0-G-F-C-C0 and LS0/LS00-B0/B0 0-E-D). As
OL3 integrates structural elements of L, we refer to this portion
of thecomplexas theaugmentedOL3 (OL3A) domain.Thedistinc-4 Structure 25, 1–14, January 3, 2017tivelybent geometryof theheterodimer is dictatedby theprincipal
axes of My4 and OL3A forming a 100 angle along the longest
dimension of the complex. This, coupled with the 18.2-A˚-long
LH region (Pro
607-Pro617, Ca-Ca distance) that acts as a spacer
between the domains, allows for the positioning of the second
OL3:My4L complex within the tetrameric assembly (Figure 2A).
OL3A is an example of fold complementation (Figure 3C), and
the isolated OL3 domain is best described as an incomplete Ig
of the intermediate-set (I-set) subfamily (Harpaz and Chothia,
1994). This type of Ig is often found in muscle proteins (Otey
et al., 2009) and consists of a total of nine strands arranged
into two distinct b sheets (A-B-E-D and A0-G-F-C-C0), exhibiting
the characteristic discontinuous A/A0 strand distributed over
both b sheets (Figure S4A). In OL3, the A b strand that is
hydrogen-bonded to B is missing and is replaced by myomesin
LS0 (Ser
618-Thr622), thus re-establishing a complete Ig archi-
tecture. A second myomesin strand (LS00, Ile
626-Glu630) also
hydrogen bonds to B00 at a position that is reminiscent of the A0
positioning found in a few deviant I-set Ig domains, identified
as the I*-set subtype (Pernigo et al., 2015). Members of this
subtype feature a relocation of their A0 strand, resulting in the
formation of an A/A0-B-E-D b sheet (Figure S4B). Thus, OL3A is
a complex trans-complemented hybrid I/I*-set Ig fold.
Molecular Interfaces
Two sets of molecular interfaces are present in the crystallo-
graphic structure. The first one is involved in the formation of
the OL3:My4L heterodimer. An additional set of interactions en-
ables its dimerization. As SEC analysis indicates that in solution
the formation of the (OL3:My4L)2 assembly is promoted by high
concentration of the complex (Figure 2B), this implies that homo-
dimerization is hierarchically secondary to the establishment
of the OL3:My4L interface.
As highlighted in the contact maps in Figures 3D and 3E,
the OL3:My4L heterodimer is held together by Ig-fold comple-
mentation. A mixture of hydrogen bonds and hydrophobic inter-
actions stabilizes the heterodimer (Figure 3F). One edge of the
Figure 3. OL3:My4L Heterodimer
(A and B) Cartoon representation of the OL3:My4L heterodimer. The view in (B) is rotated by 90 around the x axis compared with (A). My4L and
OL3 are shown in slate blue and green, respectively. In (A), the three main regions contributing to the complex are highlighted: the My4 Fn-III domain,
its C-terminal helical spacer LH, and the OL3A (A for augmented) domain in which the Ig OL3 domain is stabilized by myomesin fold complementation
in-trans.
(C) Topology diagram of the complex.
(legend continued on next page)
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0/B0 0-E-D b sheet is engendered by the anti-par-
allel pairing of LS0-B
00 and LS00-B0 b strands mediated by a total of
11 main-chain hydrogen bonds (in cyan in Figure 3F) connecting
LS0/LS00 residues to B
0/B0 0 residues. Side chains also stabilize the
complex by hydrogen bonding (in pink in Figure 3F). They typi-
cally involve hydroxyl groups of Thr and Ser residues (myomesin
S618, T628 and OL3 T328, S330) interacting with main-chain
carbonyl oxygen atoms. A single salt bridge connects the
carboxylate of myomesin E630 to the amine side chain of OL3
K305. A number of hydrophobic residues are buried upon com-
plex formation. For example, myomesin I625 points its aliphatic
side chain in a tight cavity lined by OL3 F265, W279, L304, Y317,
C319, V332. Together withmyomesin P620, T622, and V627, this
residue buries more than 90% of its surface in the interaction,
representing a critical determinant for binding. Overall, the
OL3:My4L interface area is 1,046 A˚2.
OL3:My4L homodimerization further stabilizes the assembly,
resulting in the establishment of an interface area of 2,320 A˚2
(Figure S5). This is largely engendered by OL3*:My4L (and sym-
metric OL3:My4L*, where * indicates that the domain belongs to
the dimer partner), while My4L:My4L* and OL3:OL3* interactions
are rather limited with interface areas of 122 A˚2 and 278 A˚2,
respectively. PISA analysis (Krissinel and Henrick, 2007) indi-
cates positive DG dissociation values of 14.5 kcal/mol and
12.75 kcal/mol for (OL3:My4L)2 and OL3:My4L stable assem-
blies, respectively.
Molecular Basis for Myomesin Isoform Specificity
The myomesin gene family comprises three MYOM genes in
humans (Schoenauer et al., 2008). MYOM1 encodes the ubiq-
uitously expressed myomesin protein, while MYOM2 and
MYOM3 encode a fast-fiber isoform called M protein or myome-
sin-2 and myomesin-3, a recently identified isoform of slow
fibers, respectively. The interaction with obscurin/obscurin-
like-1 is limited to myomesin, as neither M protein nor myome-
sin-3 shows any appreciable binding (Fukuzawa et al., 2008).
Our X-ray structure explains the molecular basis for this speci-
ficity. Three myomesin residues mapping onto the L linker
(T622, I625, and V627) display side chains that are complemen-
tary to the OL3 surface (Figure 4A). These are not conserved in
either M protein or myomesin-3 and occasionally exhibit rather
dramatic amino acid substitutions. For example, myomesin
T622 is replaced by a lysine in M protein, while in myomesin-3
a more polar threonine takes the place of myomesin I625
(Figure 3E).
To validate the interaction between myomesin and obscurin/
obscurin-like-1 in the context of the sarcomere, we generated
a number of myomesin variants targeting the L linker and tested
them for their ability to compete endogenous obscurin from the
M-band. A quantitative analysis of these results is summarized in
Figure 4B, while immunofluorescence images of representative
experiments are shown in Figures 4C–4G and S6. When overex-(D and E) Sequence alignment of the linker region for the different myomesin iso
lighted. Colored circles above the secondary structure cartoons show residues
proportional to the buried area. The letter codes H and S indicate residues involv
(F) Enlarged stick representation of the boxed region in the top left-hand corner (v
important myomesin:obscurin-like-1 interactions. Nitrogen, oxygen, and sulfur ato
main-chain atoms only are shown as dotted cyan lines. H bonds and salt bridge
6 Structure 25, 1–14, January 3, 2017pressed in neonatal rat cardiomyocytes (NRCs), GFP-My4LMy5
targets the M-band, in addition to other diffuse subcellular local-
izations, displacing endogenous obscurin (first bar in Figures 4B
and 4C). In the case of T622, its replacement with an isosteric
valine (T622V) does not significantly alter the wild-type behavior
(second bar in Figures 5B and 4D). This is consistent with the lack
of hydrogen bonding between the side chain of T622 and OL3
residues contributing to the small receptor cavity (Figures 3F
and 4A). However, when T622 is replaced by a lysine (T622K)
as in M protein (third bar in Figures 4B and 4E), or alternatively
when I625 is replaced by a threonine like in myomesin-3 (fourth
bar in Figures 4B and 4F), competition is essentially abrogated. A
similar effect is mediated by the V627Y replacement also found
in M protein (fifth bar in Figures 4B and 4G). As expected, control
substitutions targeting myomesin regions not involved in the
interface have no effect on the ability to compete endogenous
obscurin (Figure S6).
The OL3:My4L Heterodimer Is a Flexible Structural
Element
The bent dumbbell shape of OL3:My4L observed in the crystal
is stabilized by its homodimeric assembly. As SEC analysis indi-
cates that the complex is predominantly monomeric in solution,
we explored whether this geometry is representative of the com-
plex in solution using small-angle X-ray scattering (SAXS). The
overall molecular parameters derived from scattering data on
OL3:My4L and OL3:My4LMy5 are shown in Figure 5A. A com-
parison of the experimental radius of gyration Rg for OL3:My4L
(25.2 ± 2 A˚) with that calculated from the structure (28.9 A˚) indi-
cates that in solution, the complex adopts a less extended
conformation than in the crystal. Accordingly, the scattering
pattern computed from the crystallographic model yielded a
suboptimal fit (c = 1.91) to the SAXS data (Figure 5B, upper
curve, blue line), suggesting differences in the relative domain
arrangement. To investigate the structure in solution, we consid-
ered the complex composed of three rigid bodies defined by the
My4, LH, and OL3A structural regions (Figure 3A). A good fit to
the scattering curve was obtained with a model that is more
compact than that seen in the crystal. We then used this struc-
ture as a starting template and, following energy minimization,
generated >30,000 additional models (a selection shown in Fig-
ure 5C) using the tCONCOORD (Seeliger et al., 2007) algorithm, a
computationally efficient method for sampling conformational
transitions. Within this large pool, we found 500 models that
provide an excellent fit (c < 1.0) to the experimental curves (Fig-
ure 5B, upper panel, red line). Thesemodels all display the LH he-
lix resting on the OL3A domain, resulting in a less extended
conformation compared with the dimer-stabilized crystal struc-
ture (a selection shown in Figure 5D). Additional SAXS data
measured on OL3:My4LMy5 reveal that inclusion of the My5
domain increases theRg value to 31.0 ± 2 A˚ (Figure 5A). Tomodel
this complex, we started from the OL3:My4L solution model andforms (D) and of the OL3 and O3 domains (E). Identical amino acids are high-
of one domain contacting the other as indicated in the inset. Their radius is
ed hydrogen bonds and salt bridges, respectively.
iew rotated approximately 90 around the x axis compared with B) highlighting
ms are shown in blue, red, and yellow, respectively. Hydrogen bonds involving
s involving side chains are indicated by dotted magenta lines.
(legend on next page)
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following addition of an additional Ig domain (My5). Several
similar models provide an excellent fit (c < 1.0) to the scattering
curve (Figure 5B, lower curve). We find that the OL3:My4L
portion of the complex remains largely invariant, with My5
approximately orthogonal to OL3A (Figure 5F).
The ability of OL3:My4L to transition from the solution confor-
mation to that observed crystallographically suggests that the LH
helix might have a degree of flexibility. We explored this by solv-
ing the crystal structure of My4LH (myomesin residues 510–618)
in two different space groups (data collection and refinement
statistics in Table 1). In space group P65 (2.05 A˚ resolution), all
four My4LH independent molecules in the a.u. display clear elec-
tron density until residue A608, while residues E609-S618 (LH)
cannot be modeled (Figure S7A). The same applies for four of
six My4LH independent molecules in the alternative P21 space
group (2.80 A˚ resolution). However, in the latter crystal structure,
crystal contacts stabilize the C-terminal region in the remaining
two other My4LH molecules. While in one molecule, LH folds
into an a helix as in the My4L:OL3 complex (Figure S7B), in the
other molecule the C terminus is in a more extended conforma-
tion (Figure S7C). Overall, SAXS and crystallographic analyses
support a model in which interdomain freedom allows the transi-
tion (see Movie S1) from a relatively compact solution conforma-
tion to an open one that can be stabilized by homodimerization.
Mechanical Stability of the Complex
It is enticing to speculate that the physical connection via
swapped secondary structure elements might act as the
molecular glue necessary for the mechanical stability of the
obscurin(-like-1):myomesin assembly. To probe this, we em-
ployed single-molecule force spectroscopy using atomic force
microscopy (AFM), and guided by the structure, we fused the
C terminus of the myomesin L linker to the N terminus of OL3
by an unstructured 43 amino acids connector. This single-chain
L-(connector)43-OL3 complex was then sandwiched between
two ubiquitin (Ub) domains that serve as well-characterized han-
dles (Carrion-Vazquez et al., 2003) (Figure 6A). The engineered
polyprotein enables the unambiguous characterization of the
forces required to break the molecular interactions that hold
the complex together.
When stretched in our AFM setup at the constant velocity of
400 nm s1 often employed in these types of studies (del Rio
et al., 2009; Garcia-Manyes et al., 2012; Perez-Jimenez et al.,
2006), the polyprotein unfolded displaying a saw-tooth pattern
with peaks of alternating mechanical stability (Figure 6B). At
the beginning of the trace, we identified two mechanical events
with associated contour length increments of DL1 = 20.2 ±Figure 4. Cellular Validation and Myomesin Isoform Specificity
(A) Close up of the OL3:My4L interface. OL3 is shown as surface representatio
interacting with OL3 is shown as stick representation.
(B) Quantification of endogenous obscurin displaced in neonatal rat cardiomyocy
T622K (n = 9), I625T (n = 10), V627Y (n = 13) variants. Amino acid replacements in t
sequences abrogate competition. Error bars are SEM values. ***p% 0.001.
(C) Example of the competitive effect of overexpressed GFP-fused My4LMy5 (W
myomesin, GFP, endogenous obscurin, as well as the combined and ratiometric i
The false-color scale range indicator shows an increased obscurin/myomesin ra
(D–G) Similar to (C) for overexpressed GFP-fused My4LMy5 T622V (D), T622K (E
8 Structure 25, 1–14, January 3, 20171.2 nm (n = 66) and DL2 = 31.0 ± 0.9 nm (n = 68), respectively,
followed by the unfolding of the two ubiquitin monomers (DLUb
24.5 nm), which serve as internal molecular calibration finger-
prints (Figure 5B). Interestingly, the observed unfolding pattern
does not follow the expected hierarchy of mechanical stability
(Li and Fernandez, 2003). The first event occurs at a force value
of 129.4 ± 27.0 pN (n = 66) while the second one only requires
86.6 ± 29.1 pN (n = 68) (Figure 5C). Both mechanical events
are followed by the unfolding of the two Ubmonomers, occurring
at a higher force 200 pN (Carrion-Vazquez et al., 2003). Such
unfolding scenario is hence reminiscent of a molecular mecha-
nism whereby a mechanically labile domain is mechanically pro-
tected from the pulling force by a more resilient protein structure
(Peng and Li, 2009).
The crystal structure shows that a stretch of 15 amino acids
belonging to L lies within the OL3 domain. As the engineered
protein connector is 43 residues long, the predicted length in-
crease as a result of L detachment from OL3 is DL1=((15 + 43)
residues 3 0.36 nm/residue) = 20.88 nm. This value is in agree-
ment with the experimental measurement (DL1 = 20.2 ± 1.2 nm,
Figure 5D). The second unfolding event (DL2 = 31.0 ± 0.9 nm)
corresponds to the unfolding and stretching of OL3 (89 amino
acids). Thus, the single-molecule unfolding trajectories support
an unfolding scenario whereby the first high-force event corre-
sponds to the removal of the L linker from the OL3 domain,
followed by the unfolding of OL3, occurring at a significantly
lower force. To further confirm our molecular hypothesis, we
constructed a second polyprotein in which the flexible connector
length was lengthened to 64 residues. This new construct
confirmed forces of 143 ± 29 pN (DL1 = 27.9 ± 1.5 nm) and
81 ± 22 pN (DL2 = 31.7 ± 1.2), for the detachment of the L latch
and OL3 unfolding, respectively. As expected, while DL2 is
invariant in the two polyproteins, the longerDL1 is fully consistent
with the predicted extension of 28.4 nm ((15 + 64) residues 3
0.36 nm/residue) for the longer connector (Figure S8). Our sin-
gle-molecule nanomechanical experiments thus unambiguously
support a molecular organization in which the mechanically
labile OL3 domain is protected from force by a more resilient
architecture afforded by myomesin L complementation (Peng
and Li, 2009).
DISCUSSION
The reason why muscle sarcomeres do not self-destruct during
contraction lies in the intricate yet poorly understood cytoskel-
etal protein networks coordinated by titin at the Z disk and
M-band, which link actin andmyosin filament networks transver-
sally and longitudinally (Horowits et al., 1986). The M-bandn and colored according to its electrostatic potential. The myomesin L linker
tes expressing GFP-fused wild-type My4LMy5 (n = 11) and its T622V (n = 10),
he L linker inspired bymyomesin-2 (T622K and V627Y) andmyomesin-3 (I625T)
T) on endogenous obscurin in NRCs. The separate channels for endogenous
mages with overlaid GFPmask for the outline of the transfected cell are shown.
tio. The scale bar represents 10 mm.
), I625T (F), and V627Y (G). The scale bar represents 10 mm.
Figure 5. Small-Angle X-Ray Scattering Analysis of the Myomesin:Obscurin-Like-1 Complex
(A) Molecular parameters calculated from SAXS data. MM, Rg, Dmax are the molecular mass, radius of gyration, and maximum size, respectively. The superscript
exp denotes experimental values while xt, ai, and tC refer to crystal, ab initio, and tCONCOORD fitted models, respectively. MMcalc is the theoretical MM
computed from the protein sequence. c is the discrepancy between experimental data and those computed from models.
(legend continued on next page)
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Figure 6. Fold Complementation by the My-
omesin L Linker Protects the Mechanically
Labile OL3 Domain
(A) Schematics of the ubiquitin-L-(connector)-OL3-
ubiquitin polyprotein used in the single-molecule
mechanical experiment. The 43 amino acid flexible
connector covalently joining L to OL3 is depicted
as a dashed line. The color code for L and OL3 is
as in previous images. Ubiquitin (Ub) molecules
bracketing the complex are in gray while the gold
substrate and the atomic force microscopy (AFM)
cantilever tip are shown in yellow and black,
respectively.
(B) Typical force-extension trace for the ubiquitin-
L-(connector)43-OL3-ubiquitin polyprotein exhibit-
ing a saw-tooth pattern of unfolding events that
does not follow a hierarchy in the mechanical
stability: the first unfolding event occurs at higher
forces than the second unfolding event. The
unfolding of the ubiquitin modules, occurring
at forces of 200 pN and characterized by an
increment of contour length of DLUb 24.5 nm,
ensures the single-molecule nature of the
experiment.
(C) Histogram of unfolding forces. The first two
events can be readily identified in light of their
different mechanical stability and increment in
contour length. While the first peak occurs at
forces as high as 129.4 ± 27.0 pN (n = 66), the second peak unfolds at the markedly lower force of 86.6 ± 29.1 pN (n = 68).
(D) Histogram of contour length increase: DL1 = 20.2 ± 1.2 nm (n = 66) and DL2 = 31.0 ± 0.9 nm (n = 68). In (C) and (D), colored curves are Gaussian fits.
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key role as a mechanical safeguard during force-generating cy-
cles and as a signaling hub (Agarkova et al., 2003). Compared
with the Z disk, there is currently limited knowledge of this sarco-
meric region. The reason for this is 2-fold. On the one hand,
although the identity of some key M-band proteins is well estab-
lished, new components are steadily emerging, suggesting that
a much richer complement resides either stably or transiently at
this region. For example, cardiomyopathy associated 5 protein
(Cmya5 or myospryn) has been recently shown to bind to
M-band titin and calpain-3 (Capn3) protease (Sarparanta et al.,
2010). Mutations in Capn3 lead to limb girdle muscle dystrophy
(LGDM) type 2A, and secondary Capn3 deficiency occurs in
LGMD type 2J. Also, a novel leucine-rich protein named myo-
masp ([myosin-interacting, M-band-associated stress-respon-
sive protein]/LRRC39) has been detected as an interactor of
myosin heavy chain (MYH7), and knockdown of the myomasp/
LRRC39 ortholog in zebrafish resulted in severely impaired heart
function and cardiomyopathy in vivo (Will et al., 2010). On the
other hand, even for known M-band protein components,
complexity is such that their detailed molecular organization is
still largely unknown. Thus, advances in our understanding of
M-band biology need to address its dynamic proteome, and(B) Experimental scattering intensities for OL3:My4L (upper curve) and OL3:My4L
the crystallographic model and the best tC models are shown as solid blue and
shown as a dotted green line.
(C) Cartoon-tube representation of a selection of 20 OL3:My4L tCONCOORDmo
blue and OL3 is in green.
(D) Cartoon-tube representation of the ten OL3:My4L tCONCOORD models prov
(E and F) OL3:My4L SAXS molecular envelope calculated from the ab initio mode
like (E) for OL3:My4LMy5.
10 Structure 25, 1–14, January 3, 2017the mechanical and architectural aspects underpinning its
function.
In this work, we explored the myomesin-dependent anchoring
of obscurin-like-1 to the M-band and found a mechanism that is
new in the sarcomere context. The structure of the obscurin-
like-1:myomesin complex reveals that the myomesin L linker be-
tween its fourth (My4) and fifth (My5) Fn-III domains integrates
within the incomplete third Ig domain of obscurin-like-1 (OL3),
resulting in a stable protein complex. The mechanism of fold
complementation in-trans observed for the My4L:OL3 complex
is somewhat reminiscent of that of subunit-subunit and chap-
erone-subunit interactions in bacterial pili assembled by the
chaperone-usher pathway, whereby the binding partner inserts
a b strand into a partial Ig domain, thus restoring its fold (Remaut
et al., 2006). In the case of OL3:My4L, this binding mode pro-
vides a surprisingly high mechanical stability to the complex
(135 pN), a rupture force significantly higher than that required
to unfold OL3 alone (85 pN) and quantitatively similar to that
exhibited by the myomesin C-terminal dimer (137 pN) (Berke-
meier et al., 2011) required for myosin crosslinking. The high
force that the complex is able to withstand contrasts with the
mechanical lability (30 pN) measured for the titin:obscurin/
obscurin-like-1 complex between M10:OL1/O1 Ig domainsMy5 (lower curve) are displayed as dots with error bars. Curves computed from
red lines, respectively, while the curve computed from the ab initio models is
dels (out of >30,000) aligned with respect to their My4 domain. My4L is in slate
iding the best fit to the SAXS data (0.78 < c < 0.81).
l with a representative tCONCOORD model in two orthogonal orientations; (F)
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flects a completely different structural architecture, based on
a parallel b-strand augmentation in an Ig:Ig chevron-shaped
zipper module (Pernigo et al., 2010, 2015; Sauer et al., 2010).
Interestingly, the low rupture force of the latter interaction is on
the order of only about six myosin crossbridges, thus stable
anchoring of obscurin-like-1 to the M-band appears to be
dependent on its binding to myomesin rather than to titin. Given
the high sequence similarity between OL3 and obscurin O3,
particularly for the residues involved in the molecular interface
with myomesin (Figure 3E), we suggest that the same holds
true for obscurin anchoring and that the obscurin:myomesin
complex recapitulates OL3:My4L in its binding mode. This
closely mirrors the behavior of N-terminal Ig domains OL1 and
O1 that interact with titin M10 in a mutually exclusive manner
using a common interface. However, as for OL1 and O1, where
minor, yet significant, structural differences suggest different
specificities for putative additional partners (Pernigo et al.,
2015), we cannot exclude a similar unanticipated behavior for
OL3/O3 as well. Interestingly, both OL3 and O3 are insoluble in
bacteria when expressed in isolation, while co-expression in
the presence of the myomesin L region results in biochemically
well-behaved complexes. This suggests a chaperone effect by
myomesin, effectively enabling the correct folding of the uncon-
ventional augmented O(L)3A Ig domain. Crucially, removal of the
L linker from OL3A results in a semi-folded state with a signifi-
cantly decreased mechanical stability, requiring only 85 pN
to unfold.
A mechanism of b strand complementation between linkers
or non-structured regions with incomplete Ig domains has
also been observed, both in-cis and in-trans, in Ig domains of
the actin crosslinking protein filamin. Filamin A can interact
with the cytoplasmic tail of integrin 3 via its Ig-like domain 21
(FLNa21), but FLNa21 can also bind to the linker between
FLNa20 and 21 in an intramolecular complex that competes
with integrin. Intriguingly, the removal of the trans-comple-
mented b strand from FLNa21 unmasks the binding site for
integrin, which, when bound to filamin, engages integrin an
inactive state (Heikkinen et al., 2009; Liu et al., 2015). This spe-
cific interaction can be opened by mechanical stretch and
triggers integrin binding, filamin’s partner in mechanosensing
(Chen et al., 2009; Seppala et al., 2015). The intermolecular
domain trans-complementation we observe here for the ob-
scurin(-like-1):myomesin complex might therefore also play a
role in mechanosensing, by freeing the O3/OL3 domain for
binding to an alternative ligand. As obscurin-like-1 has been
linked to ubiquitin-mediated turnover, such a mechanosensing
pathway around the obscurin/obscurin-like-1:myomesin com-
plex might feed into the activity of the turnover of sarcomere-
associated structures (Lange et al., 2012). Myomesin crosslinks
myosin filaments and therefore must expose at least some of
the shear forces developing transversally to the myosin filament
axis, but the extent to which myomesin is directly exposed to
mechanical force in vivo remains unknown, not least because
the exact orientation with respect to the filament axis can
currently be only indirectly inferred, and the geometry of force
transmission is therefore unclear. It is also yet unclear in
which directionality mechanical forces act on the titin-obscurin,
which might be relevant based on recent molecular dynamicssimulations (Caldwell et al., 2015). However, it is reason-
able to speculate that the extremely stable anchoring of
obscurin(-like-1) to myomesin is not only structurally important,
but has evolved as functionally relevant for nanomechanical ne-
cessity, supporting the notion that the M-band is a key strain
sensor in muscle sarcomeres (Agarkova et al., 2003; Pinotsis
et al., 2012; Xiao and Grater, 2014).
The MYOM gene family codes for three proteins sharing
a similar Ig/Fn-III-rich domain organization. Our OL3:My4L
structure offers a clear structural basis for the specificity of
obscurin(-like-1) binding to the myomesin-1 isoform that was
validated by competition assays in the relevant cellular context
of NRCs. Interestingly, the OL3:My4L complex also reveals
interdomain flexibility and the ability to dimerize. The dimeric
arrangement observed in the crystal and in solution at high pro-
tein concentration opens the possibility that this geometry might
reflect the local obscurin(-like-1):myomesin organization in
the crowded environment of the sarcomere. The M4/M40 lines
typical of striated muscles define a hexagonal arrangement of
myosin filaments in the super lattices of most vertebrates.
Antibody mapping experiments suggested that the N-terminal
region of myomesin runs roughly perpendicular to the myosin
filament since My1 and the L loop are only 7 nm apart from the
M1 line (Obermann et al., 1996). Thus, it is conceivable that my-
omesin molecules emanating from neighboringmyosin filaments
of the hexagonal lattice cross over at the level of the L linker as
seen in the OL3:My4L dimer (Figure 7). The intrinsic flexibility
of the complex monomer coupled with the presence of the heli-
cal spacer at the L N terminus appears perfectly poised for this.
This suggestion is compatible with previous M-band models
(Lange et al., 2005) but adds a novel geometric constraint. In
summary, our work provides a necessary structural and biome-
chanical reference to establish the geometrical context and me-
chanical hierarchies in M-band assembly, which will need to be
reconciled with more highly resolved in situ information of this
protein network and its response to mechanical stress.
EXPERIMENTAL PROCEDURES
Detailedmethods used for cloning, protein expression, and protein purification
are given in the Supplemental Experimental Procedures.
Crystallization
An initial vapor-diffusion sparse matrix screening performed using the sitting-
drop setup with the aid of Mosquito crystallization robot (TTP LabTech) pro-
duced hundreds of OL3:My4LMy5 microcrystals in the presence of 1.1 M
ammonium tartrate (pH 7.0) and a 1:2 protein:reservoir ratio. The protein
concentration used in the screen was 4.0 mg/mL in storage buffer (20 mM
HEPES, 150 mM NaCl, 1 mM DTT [pH 7.5]). A standard pH-precipitant
grid optimization allowed us to obtain fewer marginally larger crystals in
the presence of 0.8 M ammonium tartrate, 0.1 M sodium acetate (pH 5.5) us-
ing a 1:1 protein:reservoir ratio. These crystals, however, proved unsuitable
for diffraction experiments. To further improve crystal quality, we employed
the random MMS screening approach (D’Arcy et al., 2014). Crystals obtained
in the optimization step were harvested and stored in a solution containing
0.9 M ammonium tartrate, 0.1 M sodium acetate (pH 5.5) (hit stock). A
new sparse matrix screening was performed using various commercial
screens using a hit stock:protein:reservoir ratio of 1:2:1. Few OL3:My4LMy5
single crystals were finally obtained in the presence of 20% PEG8000, 0.1 M
Tris-HCl (pH 8.5), 0.2 M MgCl2 using the protein complex at 3.0 mg/mL.
Crystallization of My4LH is described in the Supplemental Experimental
Procedures.Structure 25, 1–14, January 3, 2017 11
Figure 7. Possible Model for the Organization of the Titin:Obscurin(-like-1):Myomesin Ternary Complex at the M-Band
Experimental complexes are shown as surface representation: OL3:My4L dimer (this work), M10:OL1 (Pernigo et al., 2010, 2015; Sauer et al., 2010), My9-M13
(Pinotsis et al., 2008, 2012).
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Crystals were cryo-protected by soaking them in their reservoir solution sup-
plemented with 20% glycerol. For OL3:My4LMy5 a 3.1 A˚ resolution dataset
was collected in space group C2 while My4LH crystallized in the alternative
space groups P65 and P2, yielding diffraction data at 2.05 A˚ and 2.8 A˚ resolu-
tion, respectively. All datasets were collected at Diamond Light Source syn-
chrotron facility (Didcot, Oxfordshire, UK) and processed with the xia2 expert
system (Winter et al., 2013) using XDS (Kabsch, 2010) and AIMLESS (Evans
and Murshudov, 2013) packages. All X-ray structures were solved by the mo-
lecular replacement method with the packageMOLREP (Vagin and Teplyakov,
2010) and refined using the programs REFMAC5 (Murshudov et al., 2011) and
BUSTER (Bricogne et al., 2011). A summary of data collection and refinement
statistics is shown in Table 1. Further details on the crystallographic methods
are available in the Supplemental Experimental Procedures.
Cellular Competition Assays in NRCs and Ratiometric Analysis
NRC isolation, culture, transfection, and staining were performed essentially
as described previously (Pernigo et al., 2010). Briefly, NRCs were transfected
with GFP-tagged transiently expressing constructs (pEGFPC2-, Clontech
Laboratories) using Escort III (Sigma-Aldrich). After 48 hr culture to promote
protein expression, cells were fixed with 4% paraformaldehyde/PBS, permea-
bilized with 0.1% Triton X-100/PBS, and then stained with the appropriate an-
tibodies. The antibodies used for the current work were as follows: MyB4, a
mouse monoclonal antibody to the myomesin domain My12 (Grove et al.,
1984); and Ob5859, a rabbit polyclonal antibody to two consecutive Ig do-
mains in obscurin, Ob58 and Ob59 (Fukuzawa et al., 2005; Young et al.,
2001). All fluorescent-conjugated secondary antibodies were purchased
from Jackson ImmunoResearch. All images for ratiometry analysis were
collected on a Zeiss LSM510 confocal microscope as described previously
(Fukuzawa et al., 2008). Image analysis was carried out as described in our
previous work (Pernigo et al., 2015). Further details are available in the Supple-
mental Experimental Procedures.
Small-Angle X-Ray Scattering
Synchrotron SAXS data for OL3:My4L and OL3:My4LMy5 were collected at the
BM29BioSAXS beamline (ESRF,Grenoble) using a Pilatus 1Mdetector (Dectris)
(Pernot et al., 2013). All samples were measured at four concentrations (0.5–12 Structure 25, 1–14, January 3, 20174.5 mg/mL in 20 mM HEPES [pH 7.5], 500 mM NaCl, 1 mM DTT buffer) in the
rangeofmomentumtransfer 0.005<s<0.608A˚1 (s=4psinq/l,where thewave-
length l is 0.9919 A˚ and 2q is the scattering angle). All experiments were per-
formedat 18Cusinga sample volumeof 30mL loaded into the flowingmeasure-
ment cell. Individual frames were processed automatically and independently
within the EDNA framework (Brennich et al., 2016). Merging of separate concen-
trations and further analysis steps were performed using a combination of tools
from the ATSAS package (Petoukhov et al., 2012). Initial rigid body modeling of
the complex was done with CORAL (Petoukhov et al., 2012) and domain dy-
namics of the protein complexes was further explored by generating conforma-
tional ensembles using the tCONCOORD (Seeliger et al., 2007) method. Further
details are available in the Supplemental Experimental Procedures.
Single-Molecule Mechanical Experiments by Atomic Force
Microscopy
cDNA was commercially synthesized (Genscript), which allowed the expres-
sion of a polyprotein in which the myomesin linker L and the obscurin-like-1
OL3 domain are connected by a flexible 43-amino-acid-long connector sand-
wiched between two ubiquitin (Ub) domains (Ub-L-connector-OL3-Ub). The
synthetic gene was inserted into a pQE80L vector (QIAGEN) using standard
molecular biology techniques. A PCR-based approach also allowed the exten-
sion of the connector length to 64 amino acids. Single proteins were picked up
from the surface and pulled at a constant velocity of 400 nm s1 (del Rio et al.,
2009; Garcia-Manyes et al., 2012; Perez-Jimenez et al., 2006). Further details
are available in the Supplemental Experimental Procedures.
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SI Materials and Methods 
Cloning  
The sequence for the third Ig domain of either human obscurin (residues 238-334, 
O3) or human obscurin-like 1 (residues 251-339, OL3) was subcloned between the 
EcoRI/SalI sites of the first expression cassette of an in-house generated pGEX-6P-
2rbs vector (a kind gift of the Musacchio Lab, MPI, Dortmund). The pGEX-6P-2rbs 
vector is based on the pGEX-6P vector (GE Healthcare) but contains two expression 
cassettes separated by a ribosome binding site. Proteins expressed from the first 
cassette are C-terminal fusions to GST. The sequence for human myomesin 
encompassing the fourth and fifth Fn-III domains (residues 510-739, My4LMy5) was 
cloned between the BglII/XhoI restriction sites of the second expression cassette. 
Constructs expressing a deletion version of My4LMy5 in which the fifth Fn-III 
domain is removed (residues 510-635, My4L) were generated using the QuikChange 
kit (Stratagene) by replacing the triplet coding for residue I636 with a stop codon. 
Additionally, cDNA corresponding to myomesin residues 510-618 (My4LH) was 
cloned in an in-house modified pET9 vector. Downstream the His6-tag, this vector 
encodes for a tobacco etch virus (TEV) protease recognition sequence. All constructs 
were verified by sequencing. 
 
Protein expression and purification 
All vectors were independently transformed into the BL21 (DE3) E. coli strain to 
allow protein expression using standard methods. GST-obscurin(-like-1):myomesin 
complexes were purified by incubating the soluble fraction with Glutathione 
Superflow beads (Generon) previously equilibrated in lysis buffer for 3h at 4° C. 
After incubation the beads were extensively washed and resuspended in lysis buffer. 
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The GST tag was removed by O/N incubation of the beads suspension with 
PreScission protease (GE healthcare) at 4° C with gentle shaking. Untagged 
complexes were separated from the resin–bound protein material by centrifugation at 
400g for 15 minutes. All complexes were further purified by ion-exchange 
chromatography (IEC) and extensively dialyzed at 4°C against 50 mM Tris/HCl, 15 
mM NaCl, 1.0 mM DTT, pH 8.5 and 50 mM MES, 15 mM NaCl, 1.0 mM DTT, pH 
6.0, respectively. The O3:My4L(My5): and OL3:My4L(My5) complexes were loaded 
onto ResourceQ and ResourceS columns (GE healthcare), respectively, and eluted 
using a NaCl linear gradient. Fractions containing the complexes were pooled, 
concentrated and further purified by size-exclusion chromatography (SEC) on a 16⁄60 
HiLoad Superdex 75 column (GE Healthcare) equilibrated with 20 mM Hepes, 50 
mM NaCl, 1 mM DTT, pH 7.5. His6-My4LH was purified by immobilised metal 
affinity purification (IMAC) followed by His6-tag cleavage using TEV protease. 
Untagged My4LH was separated from the uncleaved material by a second round of 
IMAC. Flow-through fractions containing My4α were pooled, concentrated and 
further purified by (SEC) on a 16⁄60 HiLoad Superdex 75 column (GE Healthcare) 
equilibrated with 20 mM HEPES, 150 mM NaCl, 1 mM DTT, pH 7.5. 
 
Crystallisation of My4LH 
Crystallization of My4LH was accomplished using the vapor-diffusion method by 
concentrating the protein at 20 mg/ml. Optimization of hits obtained using various 
commercial screens produced diffracting crystals belonging to space group P21 and 
P65 in 25% (w/v) PEG 3350, 0.1 M BIS/Tris pH 5.5 and 21% (w/v) PEG 2000 MME, 
0.1 M Tris-HCl pH 8.8, 0.010 M NiCl2, respectively.  
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X-ray data collection and structure determination  
For the OL3:My4LMy5 complex Matthews’ coefficient calculations (Matthews, 
1968) suggested a VM of 2.87 Å3Da-1 as the most probable value. This implied the 
presence of two OL3:My4LMy5 heterodimers in the a.u. with a solvent content of 
57.2%. Using the Fn-III domain of 2NZI (Mrosek et al., 2007) as template, molecular 
replacement (MR) attempts performed using the program MOLREP (Vagin and 
Teplyakov, 2010) identified two Fn-III domains related by a 2-fold symmetry axis 
along the z axis. Further attempts at locating two additional Fn-III domains by MR 
were unsuccessful. We then decided to turn our attention to the OL3 domain. Using a 
truncated poly-Ala version of the OL1 Ig domain (PDB code 2WP3 (Pernigo et al., 
2010), a new MR search positioned two Ig domains obeying the same dyad symmetry 
of the previously positioned Fn-III domains. Model building was carried out manually 
using the program COOT (Emsley et al., 2010) and structure refinement was 
performed using the programs REFMAC5 (Murshudov et al., 2011) and BUSTER 
(Bricogne et al., 2011). Electron density maps calculated during the refinement 
process failed to reveal information on the missing Fn-III domains. The final 
deposited structure (PDB code, 5FM5) consists of a pair of OL3:My4L heterodimers 
assembled as a dimer in the crystal. The structure of My4LH was solved in space 
groups P65 and P21 by MR starting from the relevant portion of 5FM5 as template. 
Final models have been deposited with the PDB with accession codes 5FM8 and 
5FM4, respectively. A summary of refinement statistics is shown in (Table 1). 
 
Cellular competition assays in NRCs and ratiometric analysis  
Briefly, to see the competitive effect of overexpressed GFP-My4LMy5 and their 
variants on endogenous obscurin, we imported 16-bit-per-channel RGB files into 
Mathematica 10 (Wolfram Research) and translated them to ensure correct alignment 
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of the myomesin and obscurin channels. Background subtraction was performed on 
these channels by subtracting a 50-pixel radius Gaussian filtered version of that 
channel. The arctangent of the obscurin and myomesin intensities was then calculated 
on a pixel-by-pixel basis to give a ratio image of obscurin to myomesin that was 
linearly scaled between 0.0 and 1.0. A value of 0.0 corresponded to no obscurin in the 
presence of myomesin, while a value of 1.0 corresponded to obscurin in the absence 
of myomesin. A value of 0.5 corresponded to equal intensities in both channels. The 
GFP channel was binarised to create a segmented image corresponding to GFP-
positive and GFP-negative regions. The ratio image was multiplied by this mask and 
separately with an inverted version of this mask to give two ratio images that 
corresponded to the GFP-positive and GFP-negative regions of the image as two 
separate images. A histogram for each image was then determined and normalized to 
a total of 1 for each histogram. Plotting these against each other thus allowed 
comparison in shifts in ratio. A left shift (towards zero) indicated a reduction of 
obscurin in the GFP-positive ratio image. The difference between the two curves in 
this direction was calculated and the data presented represent one minus the total 
integrated difference between these two. Thus, a value of 1.0 represents total 
competition of endogenous obscurin by the GFP fusion, while a value of 0.0 
represented absence of competition. Data in Figure 5B are reported normalized to the 
obscurin competition level of GFP-My4LMy5wt (0.504±0.092, mean±s.e.m., n=11).  
 
Small angle X-ray scattering (SAXS)  
All experiments were performed at 18 °C using a sample volume of 30 µl loaded into 
the flowing measurement cell. Individual frames were processed automatically and 
independently within the EDNA framework, yielding individual radially averaged 
curves of normalized intensity. Matched buffer measurements taken before and after 
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every sample were averaged and used for background subtraction. Merging of 
separate concentrations and further analysis steps were performed using a 
combination of tools from the ATSAS package (Petoukhov et al., 2012). Standard 
procedures were applied for the computation of the forward scattering I(0), radius of 
gyration Rg, and maximum dimension Dmax. The molecular mass of the solutes was 
evaluated by comparison with reference solutions of BSA. For ab initio envelope 
reconstruction a total of 40 models were calculated for each construct using DAMMIF 
(Franke and Svergun, 2009), and then averaged, aligned and compared using 
DAMAVER (Volkov and Svergun, 2003), the output of which was used in the final 
refinement to the scattering data with DAMMIN (Svergun, 1999). Initial rigid body 
modelling of the complex was done with CORAL (Petoukhov et al., 2012) and domain 
dynamics of the protein complexes was further explored by generating 
conformational ensembles using the tCONCOORD (Seeliger et al., 2007) method. A 
total of 32768 structures were generated for each complex with this method. 
Theoretical scattering and comparison to the experimental data was done with 
PepsiSAXS.  
 
Single-molecule mechanical experiments by atomic force microscopy (AFM) 
An N-terminal His6 tag is also present to facilitate protein purification and two C-
terminal Cys residues are available at the protein C-terminus to allow protein 
attachment to the atomic force microscope. The His6-Ub-L-connector-OL3-Ub-CC 
polyproteins were purified using a combination of IMAC, IEC and SEC techniques. 
Constant velocity AFM experiments were conducted at room temperature using both 
a home-made set-up (Schlierf et al., 2004) and a commercial Luigs and Neumann 
force spectrometer (Popa et al., 2013). In all cases, the sample was prepared by 
depositing 1-10 µL of protein in PBS solution (at a concentration of 1-10 mg ml-1) 
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onto a freshly evaporated gold slide. Each cantilever (Si3N4 Bruker MLCT-AUHW) 
was individually calibrated using the equipartition theorem, giving rise to a typical 
spring constant of ~12 pN nm-1. 
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Figure S1. 
 
 
Figure S1 (related to Figure 1B, inset). OL3:My4LMy5 and O3:My4LMy5 
complexes. (A,C) During purification OL3:My4LMy5 (A) and O3:My4LMy5 (C) 
(black continuous traces) elute as 1:1 stoichiometric complexes with an apparent 
molecular weight (MW) of 36.7 kDa and 39.5, respectively, from a Superdex 75 
16/600 size-exclusion column. The calculated MW is 36.4 kDa and 36.8 kDa for 
OL3:My4LMy5 and O3:My4LMy5, respectively. The elution profile of calibration 
MW markers is shown with a broken grey line together with their MW in kDa; (B, D) 
Fractions of the OL3:My4LMy5 (B) and O3:My4LMy5 (D) peaks were analyzed by 
SDS–PAGE.  
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Figure S2. 
 
 
Figure S2. The OL3:My4LMy5 complex is not proteolyzed in the crystal (related 
to Figure 1B, inset). OL3:My4LMy5 crystals were extensively washed, dissolved in 
buffer, and analyzed by SDS-PAGE. Both My4LMy5 and OL3 domains migrate 
according to their expected molecular weight (MW) indicating that proteolysis did not 
occur during the crystallization process. The lack of electron density for the My5 
domain in crystallographic maps is likely due to flexibility of the hinge region 
connecting My4L to My5. The MW of protein markers is given on the left-hand.  
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Figure S3. 
 
 
Figure S3. OL3:My4LMy5 crystal packing (related to Figure 2A). A sliced view 
of the molecular arrangement in the crystal represented along the 2-fold (OL3:My4L)2 
axis. Large channels, highlighted by asterisks, can accommodate the My5 domain. A 
single (OL3:My4L)2 complex is highlighted with My4L shown in slate blue and OL3 
in green. Symmetry related molecules are represented in white. 
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Figure S4. 
 
 
Figure S4. Intermediate-set (I-set) Ig topologies (related to Figure 3C, inset). 
Topology diagrams of (A) I-set and (B) I*-set Ig-fold domains. The I*-set exhibits a 
relocation of the A' strand (Pernigo et al., 2015). Strands are labelled according to the 
classical Ig-fold nomenclature (Harpaz and Chothia, 1994).  
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Figure S5. 
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Figure S5 (related to Figure 2A). (OL3:My4L)2 homodimer. (A) Surface 
representation of the crystallographic (OL3:My4L)2 homodimer. My4L and OL3 are 
in slate blue and green, respectively. An asterisk is used to identify domains 
belonging to the second OL3:My4L complex; (B-C) Sequence and secondary 
structure of My4L (B) and OL3 (C). Amino acids are color-coded according to 
sequence identity as shown by the conservation bar. Colored circles identify residues 
of one domain contacting the other as indicated in the inset; (D) Homodimerization 
contact map. Light blue, light green, and yellow patches on a single OL3:My4L 
complex highlight residues interacting with My4L*, OL3*, or both domains, 
respectively. The outline of My4L is shown as a thick black line for clarity. 
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Figure S6. 
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Figure S6 (related to Figure 4). Controls for the competition assay in NRCs. (A) 
Surface representation of the OL3:My4L complex. Residues G552 and V598 that are 
not involved in establishing the OL3:My4L interface are highlighted in yellow. (B) 
Quantification of endogenous obscurin displaced in NRCs expressing GFP-fused 
wild-type My4LMy5 (n=11) and its G552Y (n=10) and V598Y (n=10) variants. As 
expected, these variants compete endogenous obscurin like the wild-type counterpart 
as their amino acid replacement does not interfere with OL3 binding; (C-D) Example 
of the competitive effect of overexpressed GFP-fused My4LMy5 G552Y (C) and 
V598Y (D). The separate channels for endogenous myomesin, GFP, endogenous 
obscurin, as well as the combined and ratiometric images with overlaid GFP mask for 
the outline of the transfected cell are shown. The false-color scale range indicator 
shows an increased obscurin/myomesin ratio. The scale-bar is 10 µm.  
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Figure S7. 
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Figure S7 (related to Figure 5). The C-terminal helix is generally disordered in 
My4LH (myomesin residues 510-618) crystals. (A-C) Close-up on the C-terminal 
region of My4LH in space group P65 (2.05 Å resolution) (A) and in space group P21 
(2.80 Å resolution) (B-C). 2mFo-DFc electron density maps are shown in blue at the 
1.0σ contour level. My4LH models are shown as sticks in slate blue. Symmetry related 
molecules are in grey. Oxygen, nitrogen, sulphur atoms are in red, blue, yellow, 
respectively. In space group P65 all four My4LH molecules in the a.u. display clear 
electron density until residue A608 while residues D609-S618 cannot be modelled 
(A). In space group P21 (six molecules/a.u) the LH region folds into a helix in one 
molecule (B) whilst in another molecule this region is more extended (C). All other 
molecules display a disordered C-terminus that could not be modelled; (D) Cartoon 
tube superposition of My4LH C-termini in helical and extended conformations.  
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Figure S8. 
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Figure S8 (related to Figure 6). Force spectroscopy measurements on the 
ubiquitin-L-(connector)68-OL3-ubiquitin polyprotein. (A) Typical force-extension 
trace for the ubiquitin-L-(connector)68-OL3-ubiquitin polyprotein. Fit to the worm-
like chain model (WLC) provides contour length increases, ΔL, from single domains 
unfolding events; (B) Histogram of domain unfolding forces. Force peaks are 
estimated at 143±29 pN (n=78), 81±22 pN (n=78), and 198±35 (n=107), for L 
unlatching, OL3 and ubiquitin unfolding, respectively; (C) Histogram of measured 
contour length increases. ∆L1=27.9±1.5 nm (n=78), ∆L2=27.9±1.5 nm (n=78), and 
∆LUb=23.8±0.6 nm (n=107), for L unlatching, OL3 and ubiquitin unfolding, 
respectively. In (B) and (C) colored curves are Gaussian fits. 
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Legend Movie S1 (related to Figure 5). Conformational transition from the compact 
conformation (as observed by SAXS) to the more extended geometry (as observed in 
the crystallographic dimer) for the OL3-My4L complex. My4L and OL3 are shown as 
surface representation in slate blue and green, respectively.  
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